DuChemBIO Co.,Ltd. (KOSDAQ:176750)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,330
-70 (-0.67%)
At close: Aug 12, 2025, 3:30 PM KST
-21.15%
Market Cap 305.84B
Revenue (ttm) 35.66B
Net Income (ttm) 7.61B
Shares Out 28.34M
EPS (ttm) 279.09
PE Ratio 38.66
Forward PE 19.55
Dividend n/a
Ex-Dividend Date n/a
Volume 32,041
Average Volume 74,837
Open 10,400
Previous Close 10,400
Day's Range 10,250 - 10,570
52-Week Range 7,070 - 19,570
Beta -0.03
RSI 55.41
Earnings Date Aug 14, 2025

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2002
Employees 115
Stock Exchange KOSDAQ
Ticker Symbol 176750
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.